5'-Fluoro-5'-deoxyaristeromycin.
Weikuan Li1, Xueqiang Yin, Stewart W Schneller
1Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, USA.
Bioorganic & Medicinal Chemistry Letters
|November 21, 2007
Summary
Researchers synthesized 5'-fluoro-5'-deoxyaristeromycin, a carbocyclic nucleoside analog. This compound showed promising antiviral activity against measles without observed cytotoxicity.
Area of Science:
- Medicinal Chemistry
- Virology
- Organic Synthesis
Background:
- Carbocyclic nucleosides are important antiviral drug candidates.
- Developing novel nucleoside analogs with diverse heterocyclic bases is crucial for expanding therapeutic options.
- Fluorinated nucleosides can exhibit unique biological activities.
Purpose of the Study:
- To synthesize a novel 5 '-fluoro-5 '-deoxycarbocyclic nucleoside analog, 5 '-fluoro-5 '-deoxyaristeromycin (2).
- To establish a versatile synthetic route for generating diverse 5 '-fluoro-5 '-deoxycarbocyclic nucleoside analogs.
- To evaluate the antiviral activity and cytotoxicity of the synthesized compound.
Main Methods:
- Synthesis of 5 '-fluoro-5 '-deoxyaristeromycin (2) using a Mitsunobu coupling reaction.
- Coupling of (1S,2S,3R,4S)-2,3-(cyclopentylidenedioxy)-4-fluoromethylcyclopentan-1-ol with N6-bis-boc protected adenine.
- Adaptation of the synthetic procedure for generating analogs with varied heterocyclic bases.
Main Results:
- Successful synthesis of 5 '-fluoro-5 '-deoxyaristeromycin (2).
- Demonstration of the adaptability of the Mitsunobu coupling method for diverse base modifications.
- Promising antiviral activity of compound 2 specifically against measles virus.
- Absence of observed cytotoxicity for compound 2.
Conclusions:
- A novel fluorinated carbocyclic nucleoside analog, 5 '-fluoro-5 '-deoxyaristeromycin, was synthesized efficiently.
- The developed synthetic strategy allows for the creation of a library of related nucleoside analogs.
- Compound 2 represents a potential lead for measles antiviral therapy due to its specific activity and lack of toxicity.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


